KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Idexx Laboratories (IDXX) Receivables - Other (2018 - 2026)

Idexx Laboratories has reported Receivables - Other over the past 8 years, most recently at $312.7 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 26.96% year-over-year to $312.7 million; the TTM value through Dec 2025 reached $312.7 million, up 26.96%, while the annual FY2025 figure was $312.7 million, 26.96% up from the prior year.
  • Receivables - Other for Q4 2025 was $312.7 million at Idexx Laboratories, up from $288.7 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $312.7 million in Q4 2025 and troughed at $122.6 million in Q1 2021.
  • A 5-year average of $211.0 million and a median of $209.0 million in 2023 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: surged 47.05% in 2021 and later rose 9.91% in 2025.
  • Year by year, Receivables - Other stood at $159.9 million in 2021, then rose by 19.32% to $190.8 million in 2022, then increased by 16.93% to $223.1 million in 2023, then increased by 10.4% to $246.3 million in 2024, then increased by 26.96% to $312.7 million in 2025.
  • Business Quant data shows Receivables - Other for IDXX at $312.7 million in Q4 2025, $288.7 million in Q3 2025, and $274.8 million in Q2 2025.